As of 2025-12-21, the Relative Valuation of Maravai LifeSciences Holdings Inc (MRVI) is (13.76) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.43 USD, the upside of Maravai LifeSciences Holdings Inc based on Relative Valuation is -501.2%.
The range of the Relative Valuation is (13.43) - (13.97) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 28.3x - 30.4x | 29.6x |
| Forward P/E multiples | 27.3x - 29.5x | 28.4x |
| Fair Price | (13.43) - (13.97) | (13.76) |
| Upside | -491.5% - -507.2% | -501.2% |
| Date | P/E |
| 2025-12-19 | -7.23 |
| 2025-12-18 | -7.42 |
| 2025-12-17 | -7.30 |
| 2025-12-16 | -7.57 |
| 2025-12-15 | -7.74 |
| 2025-12-12 | -7.59 |
| 2025-12-11 | -7.83 |
| 2025-12-10 | -7.87 |
| 2025-12-09 | -7.78 |
| 2025-12-08 | -7.61 |
| 2025-12-05 | -7.80 |
| 2025-12-04 | -7.80 |
| 2025-12-03 | -7.40 |
| 2025-12-02 | -7.26 |
| 2025-12-01 | -7.13 |
| 2025-11-28 | -7.64 |
| 2025-11-26 | -7.68 |
| 2025-11-25 | -7.93 |
| 2025-11-24 | -7.76 |
| 2025-11-21 | -7.91 |
| 2025-11-20 | -7.21 |
| 2025-11-19 | -7.38 |
| 2025-11-18 | -7.64 |
| 2025-11-17 | -7.04 |
| 2025-11-14 | -7.68 |
| 2025-11-13 | -6.85 |
| 2025-11-12 | -6.85 |
| 2025-11-11 | -6.85 |
| 2025-11-10 | -6.54 |
| 2025-11-07 | -6.05 |
| 2025-11-06 | -6.10 |
| 2025-11-05 | -6.05 |
| 2025-11-04 | -6.05 |
| 2025-11-03 | -6.20 |
| 2025-10-31 | -6.62 |
| 2025-10-30 | -6.62 |
| 2025-10-29 | -6.48 |
| 2025-10-28 | -6.81 |
| 2025-10-27 | -7.04 |
| 2025-10-24 | -7.19 |
| 2025-10-23 | -7.34 |
| 2025-10-22 | -7.19 |
| 2025-10-21 | -7.11 |
| 2025-10-20 | -7.42 |
| 2025-10-17 | -6.96 |
| 2025-10-16 | -7.36 |
| 2025-10-15 | -7.11 |
| 2025-10-14 | -6.81 |
| 2025-10-13 | -6.96 |
| 2025-10-10 | -6.73 |